Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron versus placebo in erythemato-telangiectatic rosacea
2006-003707-40Phase 2Completed
- Sponsor
- Galderma
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rosacea comparing Ondansetron with Placebo (2 arms). Primary endpoints: Change from baseline to Week 5 in combined erythema score and Week 5 combined erythema score analysis. Started Sep 2006; status: completed.
02
Drugs
ondansetron
03
Conditions
rosacea
Beyond the preview
Go deeper on 2006-003707-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003707-40.